Research and Clinical Trials

Dr. Allison Rosenthal, a Mayo Clinic hematologist specializing in lymphoma, answered questions about the disease in a Reddit AMA.

Dr. Richard Vile, a Mayo Clinic immunologist and cancer researcher, explains how CAR-T cell therapy works, including the benefits, risks and realities of treatment.

Drs. Haidong Dong and Svetomir Markovic, Mayo Clinic immunologists, discuss how immunotherapy works, its benefits and risks, and why they’re excited about its future.

Mayo Clinic researchers have developed organoid models for uveal melanoma, a type of eye cancer in adults, to better understand the disease and develop new treatments.

Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies.

Study results show people with grade 4 glioblastoma may benefit from a new approach to treatment that uses advanced imaging and proton beam therapy.

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Study demonstrates potentially effective treatment for people with bladder cancer who no longer respond to Bacillus Calmette-Guérin (BCG).

An overview of the 10 most popular articles Mayo Clinic Comprehensive Cancer Center Blog published in 2024.